Immunology, Transplantation, Internal medicine, Immunosuppression and Virology are her primary areas of study. Her work on Immunology deals in particular with CD8, T cell, ELISPOT, Immune system and Antigen. Petra Reinke studies Kidney transplantation which is a part of Transplantation.
The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Surgery. Petra Reinke has researched Immunosuppression in several fields, including Epstein–Barr virus and Viral load. As a member of one scientific family, she mostly works in the field of Virology, focusing on Immediate early protein and, on occasion, Interferon.
The scientist’s investigation covers issues in Immunology, Transplantation, Internal medicine, Kidney transplantation and Immunosuppression. Her research on Immunology often connects related areas such as Virology. Her Transplantation study also includes fields such as
Her research integrates issues of Gastroenterology, Endocrinology and Oncology in her study of Internal medicine. Her work deals with themes such as Urology, Tacrolimus and Renal function, which intersect with Kidney transplantation. Her Immunosuppression study combines topics from a wide range of disciplines, such as ELISPOT and Immunity.
Petra Reinke mainly focuses on Kidney transplantation, Immunology, Internal medicine, Transplantation and Immunosuppression. Her Kidney transplantation research includes themes of Urology, Human leukocyte antigen and Renal function. Her research ties Kidney transplant and Immunology together.
Her research investigates the connection with Internal medicine and areas like Gastroenterology which intersect with concerns in Rituximab. Petra Reinke studies Transplantation, focusing on Organ transplantation in particular. Her Immunosuppression research is multidisciplinary, incorporating perspectives in Tacrolimus and Calcineurin.
Her scientific interests lie mostly in Immunology, Kidney transplantation, Internal medicine, Transplantation and Immune system. Immunology and Receptor are commonly linked in her work. Her Kidney transplantation study integrates concerns from other disciplines, such as Congenital cytomegalovirus infection, Immunosuppression, Viral load and Renal function.
The concepts of her Internal medicine study are interwoven with issues in Gastroenterology, Diabetes mellitus, Endocrinology and Cellular differentiation. Her studies in Transplantation integrate themes in fields like FOXP3, Human leukocyte antigen, Oncology and Allorecognition. She combines subjects such as Adipogenesis, In vitro, Mesenchymal stem cell, Phenotype and In vivo with her study of Immune system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
Christian Meisel;Joerg C. Schefold;Rene Pschowski;Tycho Baumann.
American Journal of Respiratory and Critical Care Medicine (2009)
Monocyte deactivation--rationale for a new therapeutic strategy in sepsis.
H D Volk;P Reinke;D Krausch;H Zuckermann.
Intensive Care Medicine (1996)
Comparison of adefovir and tenofovir in the treatment of lamivudine‐resistant hepatitis B virus infection
Florian van Bömmel;Thomas Wünsche;Stefan Mauss;Petra Reinke.
Hepatology (2003)
Protection from cytomegalovirus after transplantation is correlated with immediate early 1–specific CD8 T cells
Torsten Bunde;Alexander Kirchner;Bodo Hoffmeister;Dirk Habedank.
Journal of Experimental Medicine (2005)
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.
Klemens Budde;Thomas Becker;Wolfgang Arns;Claudia Sommerer.
The Lancet (2011)
Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
Nils Lachmann;Paul I. Terasaki;Klemens Budde;Lutz Liefeldt.
Transplantation (2009)
Target Structures of the CD8+-T-Cell Response to Human Cytomegalovirus: the 72-Kilodalton Major Immediate-Early Protein Revisited
Florian Kern;Ingolf Pascal Surel;Nicole Faulhaber;Claudia Frömmel.
Journal of Virology (1999)
Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor.
E Fietze;S Prösch;P Reinke;J Stein.
Transplantation (1994)
T-CELL EPITOPE MAPPING BY FLOW CYTOMETRY
Florian Kern;Ingolf Pascal Surel;Carsten Brock;Bernd Freistedt.
Nature Medicine (1998)
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial
Ralf Trappe;Stephan Oertel;Veronique Leblond;Peter Mollee.
Lancet Oncology (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Charité - University Medicine Berlin
Charité - University Medicine Berlin
Charité - University Medicine Berlin
Ludwig-Maximilians-Universität München
Charité - University Medicine Berlin
Charité - University Medicine Berlin
Memorial Sloan Kettering Cancer Center
Charité - University Medicine Berlin
University of Oxford
University of Barcelona
University of Washington
Harvard University
Technical University of Berlin
The University of Texas at Austin
Kyung Hee University
TU Wien
University of Pittsburgh
Indian Institute of Technology Kharagpur
University of Bologna
University of Freiburg
University of Genoa
Met Office
Northwestern University
University Hospital Heidelberg
University of Washington
University of California, Santa Barbara